TW Jumps 8.5% as JP Morgan Lifts Target to $136
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Tradeweb Markets has gained 8.5% over the past week to close at $119.37, outpacing the median move of 3.5% among its closest peers and carrying the stock within touching distance of the analyst consensus target.
The week's clearest development is on the Street. JP Morgan's Kenneth Worthington raised his price target to $136 from $117 on Wednesday, while maintaining his Overweight rating. That move, from a bellwether firm and filed just this morning, takes TW's mean consensus target to $127.53 against a current price of $119.37. A week ago the previous note had the stock at $109.98 with a consensus near $125.60. The stock has closed much of that gap in seven trading sessions. Below the JP Morgan headline, the direction of travel remains broadly positive. Wells Fargo raised to $125 from $118 last week. TD Cowen nudged its Hold-rated target to $107. Morgan Stanley and Barclays both lifted targets earlier this month, though both firms remain at neutral-equivalent ratings. Analyst rec differentiation ranks in the 90th percentile of the ORTEX universe, reflecting a real skew toward constructive views even with several firms sitting on the fence.
Short positioning offers little friction to the move. Short interest is running at 2.93% of free float, roughly unchanged over the past week and down about 3.4% from a month ago. Borrow availability is effectively unconstrained, with shares available to lend far exceeding current short demand. Cost to borrow is low at 0.42%, though it has ticked up roughly 29% over the week after spending much of early October in a narrow range. At these levels, neither the borrow cost nor the short position creates meaningful pressure in either direction. Options positioning adds an interesting counterpoint: the put/call ratio has collapsed to 0.07, nearly two standard deviations below its 20-day average of 0.30, and represents the lowest reading of the past year. That is a striking lack of put buying into an 8.5% weekly move, suggesting options participants are not hedging gains aggressively.
Ownership is dominated by a structural anchor. Refinitiv Parent Limited, a subsidiary of London Stock Exchange Group, held a Schedule 13D position disclosing 50.8% of the class as of March 2025. As required disclosure: that stake is as last filed around the 5% threshold event, and the position may have changed since. LSEG itself appears as the top institutional holder in the most recent data at roughly 45.9% of shares. T. Rowe Price, the next largest holder, added approximately 1.3 million shares in the most recent quarter to reach a 9.3% stake. Carmignac added over 1.5 million shares in Q2. The ownership structure means a large proportion of the float sits in a small number of hands, which partly explains the low short interest and ample borrow availability.
Attention is also running elevated. Wikipedia pageviews for Tradeweb are posting a z-score of 2.45 against the company's own 90-day history, placing retail and broader public interest well above recent norms. That dataset carries no measured link to the company's financial results, so it is colour rather than signal. Results are due on October 29, eight days away. The last print on July 30 sent the stock down 7.1% on the day and a further 4.5% over the following five sessions. The October 29 print is the next data point that matters.
Stocks in this article
See the live data behind this article on ORTEX.
Open TW on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 20:28
- Data as of
- 21 Oct 2026, 20:23
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.